Is Doximity, Inc. (DOCS) a Buy, Sell, or Hold?
NYSE : DOCS
Doximity, Inc.
$21.52 USD
-$0.69 (-3.11%)
- Volume
- 2.25M
- Average Volume
- 4.03M
- Market Capitalization
- $4.02B
- P/E Ratio
- 20.69
- Dividend Yield
- 0.00%
- Price Target
- $25.50
- Year High
- $76.51
- Year Low
- $17.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.09
Company Overview
NYSE
Jeffrey A. Tangney
Medical - Healthcare Information Services
Healthcare
DOCS
880
US
USD
Liquidity Metrics
0.01
6.09
6.09
1.41
0.00
Sales & Valuation
$644.86M
6.24
4.18
12.68
1.72
Profitability
$0.98
$196.05M
30.40%
38.77%
19.36%
17.45%
P/E Metrics
20.69
-1.64
-1.64
Analyst Price Target & Rating
$25.50
$50.00
$18.00
4/5
23 Analysts
-15.61%
Poll Results
About Doximity, Inc. (NYSE:DOCS) Stock
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California. ...
Doximity (DOCS) Declines More Than Market: Some Information for Investors
2026-07-17 19:16:10
Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.
Reasons to Retain Doximity Stock in Your Portfolio for Now
2026-07-17 15:26:13
DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026
2026-07-16 16:01:00
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before.
2026-07-15 14:26:00
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the most comprehensive independent evaluations of clinical AI safety to date. The study, conducted by ARISE, a clinical AI research team led by physicians from Stanford and.
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors
2026-07-10 19:16:13
In the closing of the recent trading day, Doximity (DOCS) stood at $21.77, denoting a -1.09% move from the preceding trading day.
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-07-03 12:32:00
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories
2026-06-30 05:33:22
Doximity issued conservative FY2027 guidance, projecting 4% revenue growth and a 49% adjusted EBITDA margin, triggering a post-earnings stock selloff. I view the selloff as a temporary dislocation and a compelling buying opportunity for value investors given DOCS's resilient core platform usage. Management emphasized record physician engagement and continued dominance of DOCS's core products despite macroeconomic and regulatory headwinds.
Doximity's AI Expansion Raises Execution Risks: Analyst
2026-06-29 13:46:31
Bank of America Securities (BofA) on Monday downgraded Doximity Inc. (NYSE:DOCS), citing limited clarity on the trajectory of revenue/margins.
Frequently Asked Questions
-
What is the current Doximity, Inc. (DOCS) stock price?
-
Doximity, Inc.(NYSE:DOCS) stock price is $21.52 in the last trading session. During the trading session, DOCS stock reached the peak price of $76.51 while $17.15 was the lowest point it dropped to. The percentage change in DOCS stock occurred in the recent session was --3.11% while the dollar amount for the price change in DOCS stock was -$0.69.
-
DOCS's industry and sector of operation?
-
The NYSE listed DOCS is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of DOCS?
-
Craig A. Overpeck | Senior Vice President of Commercial Operations
Ben Greenberg | Senior Vice President & GM Commercial Products
Bruno Miranda | Senior Vice President of Engineering
Jey Balachandran | Chief Technology Officer
Joel Davis | Senior Vice President of Product -
How many employees does DOCS have?
-
Number of DOCS employees currently stands at 880. DOCS operates from 500, 3rd Street, San Francisco, CA 94107, US.
-
Link for DOCS official website?
-
Official Website of DOCS is: https://www.doximity.com
-
How do I contact DOCS?
-
DOCS could be contacted at phone #650 549 4330 and can also be accessed through its website. DOCS operates from 500, 3rd Street, San Francisco, CA 94107, US.
-
How many shares of DOCS are traded daily?
-
The average number of DOCS shares traded daily for last 3 months was 4.03M.
-
What is the market cap of DOCS currently?
-
The market value of DOCS currently stands at $4.02B with its latest stock price at $21.52